Short interest screen · refreshed after the Sep 28, 2026 close
Highest days to cover: Healthcare
Short positions that would take the longest to unwind at normal trading volume. Days to cover divides the shares sold short by average daily volume. A higher number means short sellers would need more time to buy back shares, which can make a rally sharper.
| # | Company | Price | Today | Days to cover | Short % float | Δ short int. | Mkt cap |
|---|---|---|---|---|---|---|---|
| 101 | SANASana BiotechnologyHealthcare | $2.93 | −0.51% | 12.2 | 22.5% | 0% | $877.1M |
| 102 | VCELVericelHealthcare | $40.24 | +1.33% | 12.1 | 11.6% | +15% | $2.06B |
| 103 | WGSGeneDx HoldingsHealthcare | $85.93 | −2.79% | 12.1 | 31.3% | −2% | $2.56B |
| 104 | LYELLyell ImmunopharmaHealthcare | $9.74 | −1.12% | 12.1 | 13.4% | +5% | $238.7M |
| 105 | VNDAVanda PharmaceuticalsHealthcare | $5.17 | +2.38% | 12.1 | 15.7% | +11% | $312.6M |
| 106 | MIRMMirum PharmaceuticalsHealthcare | $87.96 | −1.94% | 12.0 | 12.5% | +2% | $5.71B |
| 107 | ABEOAbeona TherapeuticsHealthcare | $5.29 | −2.04% | 12.0 | 33.2% | +4% | $302.5M |
| 108 | DNLIDenali TherapeuticsHealthcare | $20.98 | +2.89% | 12.0 | 12.9% | +3% | $3.35B |
| 109 | RDNTRadNetHealthcare | $71.81 | +1.44% | 11.9 | 13.8% | −3% | $5.65B |
| 110 | KRROKorro BioHealthcare | $9.51 | −0.63% | 11.9 | 13.8% | +5% | $140.0M |
| 111 | COGTCogent BiosciencesHealthcare | $31.86 | −1.39% | 11.8 | 12.1% | −3% | $5.53B |
| 112 | AQSTAquestive TherapeuticsHealthcare | $4.75 | +1.50% | 11.8 | 25.2% | +7% | $596.2M |
| 113 | ANTXAN2 TherapeuticsHealthcare | $5.01 | +2.66% | 11.8 | 9.6% | −4% | $189.1M |
| 114 | JBIOJade BiosciencesHealthcare | $14.35 | −0.49% | 11.8 | 26.6% | +10% | $912.6M |
| 115 | RMDResMedHealthcare | $222.10 | +0.04% | 11.7 | 9.9% | +9% | $32.04B |
| 116 | ANNXAnnexonHealthcare | $4.01 | +10.16% | 11.7 | 21.4% | +2% | $760.2M |
| 117 | CVCapsoVisionHealthcare | $6.92 | +4.06% | 11.7 | 5.6% | +1% | $368.2M |
| 118 | AURAAura BiosciencesHealthcare | $6.15 | +2.50% | 11.7 | 7.8% | +14% | $637.8M |
| 119 | SGPSpyGlass PharmaHealthcare | $25.98 | −4.03% | 11.6 | 20.7% | +12% | $869.0M |
| 120 | ORKAOruka TherapeuticsHealthcare | $84.19 | −0.32% | 11.6 | 15.9% | −2% | $5.57B |
| 121 | HALOHalozyme TherapeuticsHealthcare | $112.89 | −0.89% | 11.6 | 13.7% | +2% | $12.81B |
| 122 | SYRESpyre TherapeuticsHealthcare | $85.79 | +0.12% | 11.6 | 15.1% | +2% | $7.56B |
| 123 | AKTSAktis OncologyHealthcare | $19.35 | −0.41% | 11.5 | 14.3% | +2% | $1.08B |
| 124 | NVCRNovoCure LimitedHealthcare | $15.83 | −0.06% | 11.5 | 11.2% | +9% | $1.84B |
| 125 | LQDALiquidiaHealthcare | $73.67 | +7.66% | 11.5 | 18.7% | +4% | $6.59B |
| 126 | MBXMBX BiosciencesHealthcare | $57.54 | +7.29% | 11.4 | 14.0% | −1% | $2.77B |
| 127 | MDGLMadrigal PharmaceuticalsHealthcare | $517.04 | +0.09% | 11.4 | 13.6% | +1% | $11.95B |
| 128 | AVRAnteris Technologies GlobalHealthcare | $7.74 | +0.65% | 11.3 | 7.9% | −8% | $754.3M |
| 129 | NAGENiagen BioscienceHealthcare | $2.98 | −2.30% | 11.3 | 7.7% | −4% | $235.8M |
| 130 | REPLReplimune GroupHealthcare | $12.56 | +1.62% | 11.1 | 36.1% | −3% | $1.18B |
| 131 | VORVor BiopharmaHealthcare | $18.31 | −1.13% | 11.1 | 20.4% | +3% | $1.08B |
| 132 | RCKTRocket PharmaceuticalsHealthcare | $2.61 | +0.58% | 11.1 | 17.6% | +1% | $286.5M |
| 133 | AUPHAurinia PharmaceuticalsHealthcare | $16.52 | +0.49% | 11.1 | 8.3% | −4% | $2.20B |
| 134 | PTCTPTC TherapeuticsHealthcare | $65.95 | +5.23% | 11.0 | 12.4% | −1% | $5.50B |
| 135 | FOSLFossil GroupHealthcare | $6.02 | −2.90% | 10.9 | 13.1% | +6% | $356.0M |
| 136 | NUVBNuvation BioHealthcare | $5.60 | −2.44% | 10.9 | 22.0% | +7% | $1.97B |
| 137 | CGEMCullinan TherapeuticsHealthcare | $14.95 | +0.95% | 10.9 | 18.0% | −7% | $962.1M |
| 138 | MDXGMiMedx GroupHealthcare | $4.68 | +0.21% | 10.9 | 9.2% | +15% | $683.0M |
| 139 | TKNOAlpha TeknovaHealthcare | $9.20 | −1.39% | 10.8 | 18.7% | +2% | $493.9M |
| 140 | SRRKScholar Rock HoldingHealthcare | $49.13 | +1.03% | 10.8 | 18.1% | +8% | $5.98B |
| 141 | ADMAADMA BiologicsHealthcare | $10.12 | +7.89% | 10.8 | 11.3% | +1% | $2.27B |
| 142 | ODTXOdyssey TherapeuticsHealthcare | $21.47 | +4.68% | 10.8 | 9.2% | 0% | $1.03B |
| 143 | KYTXKyverna TherapeuticsHealthcare | $6.82 | +0.15% | 10.8 | 23.8% | +4% | $421.8M |
| 144 | QDELQuidelOrthoHealthcare | $10.83 | −1.01% | 10.8 | 21.1% | 0% | $742.7M |
| 145 | AMPHAmphastar PharmaceuticalsHealthcare | $27.39 | +4.82% | 10.8 | 17.1% | −3% | $1.17B |
| 146 | ENTAEnanta PharmaceuticalsHealthcare | $12.62 | +6.19% | 10.7 | 9.5% | −1% | $367.4M |
| 147 | ALKSAlkermesHealthcare | $40.15 | −1.71% | 10.7 | 9.2% | +3% | $6.74B |
| 148 | TMDXTransMedics GroupHealthcare | $82.73 | −3.00% | 10.7 | 24.8% | −1% | $2.87B |
| 149 | SIBNSI-BONEHealthcare | $18.76 | +0.91% | 10.7 | 13.7% | +5% | $840.8M |
| 150 | SGMTSagimet Biosciences Inc. Series AHealthcare | $9.94 | +7.58% | 10.6 | 36.3% | +1% | $617.9M |
Data guard: 9 stocks withheld — NG (reported short interest is above 100% of float); EGO (reported short interest is above 100% of float); BNS (reported short interest is above 100% of float); AQN (reported short interest is above 100% of float); CAE (reported short interest is above 100% of float); GIL (reported short interest is above 100% of float); EPRX (reported short interest is above 100% of float); MFI (reported short interest is above 100% of float); CHRN (float record is implausibly small). They return once the float record is verified.
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.